A prospective clinical study of theophylline safety in 3810 elderly with asthma or COPD.

[1]  R. A. Zeeuw,et al.  The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease , 2004, European Journal of Clinical Pharmacology.

[2]  P. Turner,et al.  The relationship between theophylline clearance and age in adult life , 2004, European Journal of Clinical Pharmacology.

[3]  S. Jackson,et al.  The relationship between clearance of theophylline and age within the adult age range , 2004, European Journal of Clinical Pharmacology.

[4]  I. Adcock,et al.  A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Ohta,et al.  Apoptosis of eosinophils and lymphocytes in allergic inflammation. , 1999, The Journal of allergy and clinical immunology.

[6]  R. Djukanović,et al.  Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo-controlled parallel group study. , 1996, The European respiratory journal.

[7]  K. Chung,et al.  Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. , 1995, American journal of respiratory and critical care medicine.

[8]  C. Page,et al.  Anti-inflammatory effects of low-dose oral theophylline in atopic asthma , 1994, The Lancet.

[9]  M. Shannon.  Predictors of Major Toxicity after Theophylline Overdose , 1993, Annals of Internal Medicine.

[10]  R. Vestal,et al.  Aging and the response to inhibition and induction of theophylline metabolism , 1993, Experimental Gerontology.

[11]  B. Vrhovac,et al.  Pharmacokinetics and interactions of digoxin, theophylline and furosemide in diseases with edema. , 1993, International journal of clinical pharmacology, therapy, and toxicology.

[12]  S. Szefler,et al.  Safety and efficacy of theophylline in children with asthma. , 1992, The Journal of pediatrics.

[13]  R. Upton.  Pharmacokinetic Interactions Between Theophylline and Other Medication (Part II) , 1991 .

[14]  H. Jick,et al.  Hospital Admission for Xanthine Toxicity , 1990, Pharmacotherapy.

[15]  A. Colli,et al.  Disposition of a flow‐limited drug (lidocaine) and a metabolic capacity–limited drug (theophylline) in liver cirrhosis , 1988, Clinical pharmacology and therapeutics.

[16]  M. Andréjak,et al.  Effects of age on theophylline kinetics in hospitalized patients , 1988 .

[17]  N. Benowitz,et al.  Cigarette abstinence, nicotine gum, and theophylline disposition. , 1987, Annals of internal medicine.

[18]  K. Peace,et al.  The effect of age on theophylline clearance in normal subjects. , 1986, British journal of clinical pharmacology.

[19]  L. Hendeles,et al.  Therapeutic effect and dosing strategies for theophylline in the treatment of chronic asthma. , 1986, The Journal of allergy and clinical immunology.

[20]  M. V. Miles,et al.  The Effects of Acute Viral Hepatitis on Theophylline Clearance , 1985, Clinical pediatrics.

[21]  A. Staib,et al.  Pharmacokinetics and metabolism of theophylline in patients with liver diseases. , 1980, International journal of clinical pharmacology, therapy, and toxicology.

[22]  J. Lavan,et al.  Theophylline kinetics in relation to age: the importance of smoking. , 1980, British journal of clinical pharmacology.

[23]  L. Hendeles,et al.  Disposition of theophylline after a single intravenous infusion of aminophylline. , 1978, The American review of respiratory disease.

[24]  W. Jusko,et al.  Pharmacokinetics of theophylline in hepatic disease. , 1978, Chest.

[25]  R. Ogilvie,et al.  Theophylline disposition in patients with hepatic cirrhosis. , 1977, The New England journal of medicine.

[26]  R. Matthay,et al.  Theophylline-induced seizures in adults. Correlation with serum concentrations. , 1975, Annals of internal medicine.